A possible link between increased metabolic activity of fat tissue and aortic wall inflammation in subjects with COPD. A retrospective 18F-FDG-PET/CT pilot study

Respiratory Medicine

Volumn 108, Issue 6, 2014, Pages 883-890

  Vanfleteren, Lowie E G W ^a,b   Van Meerendonk, Aniek M G ^b   Franssen, Frits M ^a,b   Wouters, Emiel F M ^a,b   Mottaghy, Felix M ^b,c   Van Kroonenburgh, Marinus J ^b   Bucerius, Jan ^b,c,d  

^a CIRO+   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adipose tissue; Comorbidity; COPD; Inflammation; PET; Visceral fat

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; AGED; AORTA WALL; ARTICLE; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; INTRAABDOMINAL FAT; MALE; PRIORITY JOURNAL; SMOKING; SUBCUTANEOUS FAT; ABDOMINAL AORTA; AORTITIS; COMPLICATION; METABOLISM; PHYSIOLOGY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RETROSPECTIVE STUDY; SCINTISCANNING; VITAL CAPACITY;

AGED; AORTA, ABDOMINAL; AORTITIS; FEMALE; FLUORODEOXYGLUCOSE F18; FORCED EXPIRATORY VOLUME; HUMANS; INTRA-ABDOMINAL FAT; MALE; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SUBCUTANEOUS FAT, ABDOMINAL; VITAL CAPACITY;

EID: 84902240469     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.04.001     Document Type: Article

References (40)

1. A. Agusti, P.M. Calverley, and B. Celli et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort Respir Res 11 2010 122
2. J. Vestbo, S.S. Hurd, and A.G. Agusti et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 187 2013 347 365
3. D.M. Mannino, D. Thorn, and A. Swensen et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 32 2008 962 969
4. J.R. Feary, L.C. Rodrigues, and C.J. Smith et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 2010 956 962
5. D.M. Mannino, D.E. Doherty, and A. Sonia Buist Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study Respir Med 100 2006 115 122
6. L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799
7. A. Agusti, L.D. Edwards, and S.I. Rennard et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype PLoS One 7 2012 e37483
8. G.H. Goossens The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance Physiol Behav 94 2008 206 218
9. H.B. Hubert, M. Feinleib, and P.M. McNamara et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
10. M. Poulain, M. Doucet, and V. Drapeau et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease Chron Respir Dis 5 2008 35 41
11. M.K. Breyer, M.A. Spruit, and A.P. Celis et al. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance? Clin Nutr 28 2009 642 647
12. E.P. Rutten, M.K. Breyer, and M.A. Spruit et al. Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease Clin Nutr 29 2010 756 760
13. J. Garcia-Aymerich, F.P. Gomez, and M. Benet et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes Thorax 66 2011 430 437
14. L.E. Vanfleteren, M.A. Spruit, and M. Groenen et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 187 2013 728 735
15. T.B. Koenen, R. Stienstra, and L.J. van Tits et al. The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue Endocrinology 152 2011 3769 3778
16. S.K. Fried, D.A. Bunkin, and A.S. Greenberg Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 1998 847 850
17. B. van den Borst, H.R. Gosker, and A. Koster et al. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease Am J Clin Nutr 96 2012 516 526
18. W. Chen, G.G. Bural, and D.A. Torigian et al. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries Eur J Nucl Med Mol Imaging 36 2009 144 151
19. J.H. Rudd, K.S. Myers, and S. Bansilal et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study Circ Cardiovasc Imaging 2 2009 107 115
20. T. Christen, Y. Sheikine, and V.Z. Rocha et al. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging JACC Cardiovasc Imaging 3 2010 843 851
21. J.M. Coulson, J.H. Rudd, and J.M. Duckers et al. Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot study J Nucl Med 51 2010 1357 1360
22. J. Bucerius, R. Duivenvoorden, and V. Mani et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study JACC Cardiovasc Imaging 4 2011 1195 1205
23. F.E. Hargreave, and P. Nair The definition and diagnosis of asthma Clin Exp Allergy 39 2009 1652 1658
24. J. Vestbo, S.S. Hurd, and A.G. Agusti et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary Am J Respir Crit Care Med 187 2013 347 365
25. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1999 179 187
26. A. Tawakol, R.Q. Migrino, and G.G. Bashian et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824
27. J.H. Rudd, E.A. Warburton, and T.D. Fryer et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711
28. S.F. Pedersen, M. Graebe, and A.M. Fisker Hag et al. Gene expression and 18FDG uptake in atherosclerotic carotid plaques Nucl Med Commun 31 2010 423 429
29. K.A. Virtanen, P. Lonnroth, and R. Parkkola et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans J Clin Endocrinol Metab 87 2002 3902 3910
30. L.F. Van Gaal, I.L. Mertens, and C.E. De Block Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880
31. S.R. Bornstein, M. Abu-Asab, and A. Glasow et al. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture Diabetes 49 2000 532 538
32. N. Tahara, H. Kai, and S. Yamagishi et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 2007 1533 1539
33. J. Bucerius, V. Mani, and C. Moncrieff et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake J Am Coll Cardiol 59 2012 2080 2088
34. L. Huiart, P. Ernst, and S. Suissa Cardiovascular morbidity and mortality in COPD Chest 128 2005 2640 2646
35. S.M. Curkendall, C. DeLuise, and J.K. Jones et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients Ann Epidemiol 16 2006 63 70
36. A.K. Johnston, D.M. Mannino, and G.W. Hagan et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort Thorax 63 2008 599 605
37. R. Furutate, T. Ishii, and R. Wakabayashi et al. Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 6 2011 423 430
38. J.T. Giles, M. Allison, and R.S. Blumenthal et al. Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics Arthritis Rheum 62 2010 3173 3182
39. L. Katznelson, W.P. Fairfield, and N. Zeizafoun et al. Effects of growth hormone secretion on body composition in patients with Crohn's disease J Clin Endocrinol Metab 88 2003 5468 5472
40. A. Balci, D.D. Balci, and Z. Yonden et al. Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome Dermatology 220 2010 32 37